Group 6 Copy 73
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Geissorhiza: an evolutionary case study in the Cape Floristic Region

    The Cape Floristic Region (CFR) in South Africa is one of the most plant biodiverse places on earth with over...

    Should I stay or should I go? Connecting bird behavior during migration to fat stores and antioxidant capacity

    Thank you to our backers for $5600! We actually need up to $24000 - please keep donating! In the fall, most...

    Backer Badge Funded

    A biology project funded by 47 people